MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fimmu.2024.1475179

Медицинская библиотека · Frontiers in immunology · 2024

A novel functional IKBKE variant activating NFAT in a patient with polyarthritis and a remittent fever.

Yamada Saeko, Nagafuchi Yasuo, Yamada Mamiko, Suzuki Hisato, Natsumoto Bunki, Ota Mineto, Takazawa Ikuo, Hatano Hiroaki, Kono Masanori, Harada Hiroaki, Shoda Hirofumi, Okamura Tomohisa, Kosaki Kenjiro, Fujio Keishi

Клинический случайСтатьяПеревод в очереди

Аннотация

BACKGROUND

IKBKE is a negative regulator of T cell activation and one of the key activators of type I interferon (IFN) and NFκB signaling via non-classical pathways. The upstream single nucleotide polymorphism of IKBKE (rs2297550-G) is a genome-wide association study risk variant of systemic lupus erythematosus, and is associated with decreased IKBKE expression in T cells by expression quantitative trait locus analysis.

CASE PRESENTATION: A 48-year-old female had a remittent fever, arthritis, and oral ulcers for 20 years. She had a poor response to corticosteroids or disease-modifying antirheumatic drugs, including the tumor necrosis factor-α antagonist, etanercept, and the anti-interleukin-6 receptor antibody, tocilizumab.

METHOD: She participated in the Initiative on Rare and Undiagnosed Disease (IRUD), and whole-exome sequencing (WES) was performed. Functional analyses were conducted by transfecting the identified variants into reporter cells to assess the activation of NFAT and NFκB signaling. Additionally, peripheral blood RNA- sequencing (RNA-seq) data were compared with those from healthy individuals to evaluate the gene expression profiles of immune cells.

RESULT: WES identified a novel heterozygous c.1877G>A, p(Cys626Tyr) variant in IKBKE. Functional analysis indicated that this variant led to increased activity of NFAT (p = 0.015) and decreased activity of NFκB and type I IFN (p = 0.00068 and 0.00044, respectively). The patient had a remarkably low proportion of Naïve CD4 T cells. RNA-seq of peripheral blood immune cell subsets revealed significant differences in gene expression, especially in T cells.

CONCLUSION

A novel functional heterozygous variant in IKBKE is described in a patient with a remittent fever and arthritis. The data suggest that IKBKE is an important negative regulator of inflammation, particularly in T cells, and this IKBKE variant might be the underlying cause of a novel autoinflammatory pathology.

Для цитирования: Yamada Saeko, Nagafuchi Yasuo, Yamada Mamiko, Suzuki Hisato, Natsumoto Bunki, Ota Mineto, Takazawa Ikuo, Hatano Hiroaki, Kono Masanori, Harada Hiroaki, Shoda Hirofumi, Okamura Tomohisa, Kosaki Kenjiro, Fujio Keishi. A novel functional IKBKE variant activating NFAT in a patient with polyarthritis and a remittent fever.. Frontiers in immunology. 2024. DOI: 10.3389/fimmu.2024.1475179.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.